Completeness assessment of type II active pharmaceutical ingredient drug master files under generic drug user fee amendment: review metrics and common incomplete items.
AAPS J
; 16(5): 1132-41, 2014 Sep.
Article
in En
| MEDLINE
| ID: mdl-25034968
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
United States Food and Drug Administration
/
Drugs, Generic
/
Drug Approval
/
Drug Industry
/
Fees and Charges
Type of study:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
Country/Region as subject:
America do norte
Language:
En
Journal:
AAPS J
Year:
2014
Document type:
Article